Compare EXR & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXR | KVUE |
|---|---|---|
| Founded | 1977 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Specialty Chemicals |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 32.9B |
| IPO Year | 2004 | 2023 |
| Metric | EXR | KVUE |
|---|---|---|
| Price | $150.47 | $18.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $144.80 | $19.45 |
| AVG Volume (30 Days) | 925.3K | ★ 19.0M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | 4.61% | ★ 4.82% |
| EPS Growth | 13.90 | ★ 40.74 |
| EPS | ★ 1.14 | 0.25 |
| Revenue | $3,377,542,000.00 | ★ $15,124,000,000.00 |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | $3.63 | $2.63 |
| P/E Ratio | $131.23 | ★ $72.20 |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $125.71 | $14.02 |
| 52 Week High | $155.19 | $22.87 |
| Indicator | EXR | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 64.87 | 61.39 |
| Support Level | $136.53 | $16.89 |
| Resistance Level | $154.33 | $19.07 |
| Average True Range (ATR) | 3.05 | 0.38 |
| MACD | 0.57 | 0.08 |
| Stochastic Oscillator | 87.11 | 98.28 |
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages more than 4,200 self-storage properties in 43 states, with over 330 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.